OUR SCIENCE
WHAT IS FIBROBLAST GROWTH FACTOR?

REGEN FACTOR

R&D Skin Biology company

ReGen Factor is an Australia-based progressive R&D skin biology company with a global reach. 

ReGen Factor has developed first to market technology to produce bio-identical and cost-effective Fibroblast growth factors (FGFs) which regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration, and differentiation

DISRUPTIVE BIOTECHNOLOGY

Within the field of regenerative biology, researchers and clinicians increasingly understand that the therapeutic mechanism of Fibroblast Growth Factors (FGFs) is not engraftment or differentiation in the target tissue, but rather cell-to-cell communication. ReGen Factor’s products contain bioidentical recombinant human basic Fibroblast Growth Factor (rh bFGF AK FGF2, bFGF), are the essential Fibroblast Growth Factor mediators of tissue inflammation, regeneration, and repair. ReGen Factor views Fibroblast Growth Factors as the future of medicine itself.

FLAGSHIP PRODUCT

As the flagship product, PepFactor is the first product created from ReGen Factors’ Fibroblast Growth Factors. PepFactor is a human recombinant basic Fibroblast Growth Factor. ReGen Factor’s bio-identical and cost-effective production method is applicable to all Fibroblast Growth Factors. Fibroblast growth factors (FGFs) are a family of peptide cytokines that are important in the regulation of many tissues. To date, 23 different FGFs have been identified, including the best-characterized acidic FGF, or FGF1; basic FGF, or FGF2; and keratinocyte growth factor, or FGF7.

need new copy

new copy here...

ADVANCED MANUFACTURING

Since August of 2020, the FDA defines the term “Advanced Manufacturing” as “new medical product manufacturing that can improve drug quality, address the shortage of medications, and speed time-to-market”. ReGen Factor has since made exciting headway in the development of its proprietary advanced cost effective FGF manufacturing technology. ReGen Factor employs a bioreactor capable of producing cost-effective bioidentical to PepFactor in addition to other pipeline products in a current Good Manufacturing Practices (cGMP) environment. It can significantly increase the yield of FGF production and reduce manufacturing costs by 80%.

be part of our success.

MEET OUR EXPERTS

OUR ADVISORY BOARD

We have carefully selected our Medical Advisory board to be made up of industry and medical experts with decades of experience in the field. Ensuring that our future is strong and filled with quality research and development of groundbreaking products.

DR. HARDIK SONI

Chairman
MD, John Hopkins University, Baltimore.

DR. ROEL GALOPE

Chief Medical Officer
DO, Western University of Health Sciences
BA Science and Management, Doctorate of Osteopathic Medicine

DR. ROBERT DORIN

Co Chairman
BS, Stony Brook University, NY
Diplomate if the American Board of Hair Restoration Surgery.

DR. BEN CHAN

Medical Advisor
Experienced and entrepreneurial aesthetics doctor in the cosmetic and skin field since 1984.

KIMBERLEY VAUGHN

Chief Clinical Trial Officer
MD of HPI Hair Partners, trichologist and hair loss specialist. MBA, Masters of World Trichology.

STEPHEN BLIGNAUT

CEO
MBA, Griffith University

Get In Touch!

Fill out the form below, and we will be in touch shortly.
Contact Information
Preferred Date and Time Selection